• +1-646-491-9876
    • +91-20-67278686

    Search

    GBI Research

    Report name Publication Date Price
    (Single Copy Price)
    Buy Now
    Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review 2018
    30-Apr-2018

    $3,995.00


    Buy Now
    Influenza A Viral Infections Drug Development Pipeline Review 2018
    30-Apr-2018

    $3,995.00


    Buy Now
    Frontier Pharma-Type 2 Diabetes Mellitus-Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline with Strong Repositioning Opportunities into Associated Areas Including Obesity and Cardiovascular Disease
    01-Apr-2018

    $6,995.00


    Buy Now
    Cognitive Impairment Disorders Drug Development Pipeline Review 2018
    01-Apr-2018

    $3,995.00


    Buy Now
    HAE Therapeutics in Asia-Pacific Markets to 2023-Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies
    31-Mar-2018

    $4,995.00


    Buy Now
    Global Immunology Drugs Market to 2023-Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs
    31-Mar-2018

    $4,995.00


    Buy Now
    Non Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis Drug Development Pipeline Review 2018
    22-Mar-2018

    $3,995.00


    Buy Now
    Fungal Foot Infections Drug Development Pipeline Review 2018
    22-Mar-2018

    $3,995.00


    Buy Now
    Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023-Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
    01-Mar-2018

    $4,995.00


    Buy Now
    Global Neurodegenerative Diseases Drugs Market to 2023-MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential
    07-Feb-2018

    $4,995.00


    Buy Now
    Frontier Pharma Women's Health-An Expanding Therapy Area with Endometriosis Therapies Prominent among the First-in-Class Pipeline
    01-Feb-2018

    $6,995.00


    Buy Now
    Uveitis Therapeutics in Asia-Pacific Markets to 2023-Increasing Prevalence Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market
    01-Feb-2018

    $4,995.00


    Buy Now
    Antibacterial Therapeutics-High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance
    01-Jan-2018

    $6,995.00


    Buy Now
    Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023-Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market
    27-Dec-2017

    $4,995.00


    Buy Now
    Lower Female Reproductive System Cancers Drug Development Pipeline Review 2017
    26-Dec-2017

    $3,995.00


    Buy Now
    Bladder and Ureter Cancer Drug Development Pipeline Review 2017
    22-Dec-2017

    $3,995.00


    Buy Now
    Global Genetic Disorders Drugs Market to 2023-A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease
    15-Dec-2017

    $4,995.00


    Buy Now
    Global Cardiovascular Disease Drugs Market to 2023-Expiries Acquisitions and New Products for Deep Vein Thrombosis Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape
    01-Dec-2017

    $4,995.00


    Buy Now
    Frontier Pharma-Transplantation Therapeutics-A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation
    01-Dec-2017

    $6,995.00


    Buy Now
    COPD Therapeutics in Asia-Pacific Markets to 2023-Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
    01-Dec-2017

    $4,995.00


    Buy Now
    Swine and Avian Influenza Drug Development Pipeline Review 2017
    20-Nov-2017

    $3,995.00


    Buy Now
    Sickle Cell Disease Drug Development Pipeline Review 2017
    17-Nov-2017

    $3,995.00


    Buy Now
    Gastric and Esophageal Cancer Drug Development Pipeline Review 2017
    16-Nov-2017

    $3,995.00


    Buy Now
    Cancer Supportive Care Drug Development Pipeline Review 2017
    14-Nov-2017

    $3,995.00


    Buy Now
    Frontier Pharma: Neurodegenerative Diseases-Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD
    01-Nov-2017

    $6,995.00


    Buy Now
    Showing 1 to 25 of 163 (7 Pages)